10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes Abstract Obesity and hyperlipidemia are associated with impaired insulin sensitivity in human type 2 diabetes mellitus, possibly due to activation of a mild inflammatory response. Because obesity-induced insulin resistance predisposes cats to diabetes and because hyperlipidemia is a frequent concurrent finding, excess lipids may also impair insulin sensitivity in cats. Healthy cats (n=6) were infused with lipids (Lipovenoes 10%) for 10 days to clamp blood triglycerides at the approximate concentration of untreated feline diabetes (3-7 mmol/l). Controls received saline (n=5). On day 10, plasma adiponectin and proinflammatory markers were measured. Whole-body insulin sensitivity was calculated following an intravenous glucose tolerance test. Tissue mRNAs of glucose metabolism-related genes were quantified in subcutaneous and visceral fat, liver, and skeletal muscles. Accumulation of lipids was assessed in liver. At the termination of infusion, whole-body insulin sensitivity did not differ between groups. Compared to saline, cats infused with lipids had 50% higher plasma adiponectin and 2-3 times higher alpha(1)-acid glycoprotein and monocyte chemoattractant protein-1. Unexpectedly, lipid-infused cats had increased glucose transporter-4 (GLUT4) mRNA in the visceral fat, and increased peroxisome proliferative activated receptor-gamma2 (PPARgamma2) in subcutaneous fat; adiponectin expression was not affected in any tissue. Lipid-infused cats developed hepatic steatosis. Although hyperlipidemia induced systemic inflammation, whole-body insulin sensitivity was not impaired after 10 day infusion. Increased circulating adiponectin may have contributed to prevent insulin resistance, possibly by increasing GLUT4 and PPARgamma2 transcripts in fat depots. Obesity and hyperlipidemia are associated with impaired insulin sensitivity in human type 2 23
Obesity and hyperlipidemia are associated with impaired insulin sensitivity in human type 2 23 diabetes mellitus, possibly due to activation of a mild inflammatory response. Because 24 obesity-induced insulin resistance predisposes cats to diabetes and because hyperlipidemia is 25 a frequent concurrent finding, excess lipids may also impair insulin sensitivity in cats. 26
Healthy cats (n=6) were infused with lipids (Lipovenoes R 10%) for 10 days to clamp blood 27 triglycerides at the approximate concentration of untreated feline diabetes (3-7 mmol/l). 28
Controls received saline (n=5). On day 10, plasma adiponectin and pro-inflammatory markers 29
were measured. Whole-body insulin sensitivity was calculated following an intravenous 30 glucose tolerance test. Tissue mRNAs of glucose metabolism-related genes were quantified in 31 subcutaneous and visceral fat, liver and skeletal muscles. Accumulation of lipids was assessed 32 in liver. 33
At the termination of infusion, whole-body insulin sensitivity did not differ between groups. 34
Compared to saline, cats infused with lipids had 50% higher plasma adiponectin and 2-3 35 times higher α 1 -acid glycoprotein and monocyte chemoattractant protein-1. Unexpectedly, 36 lipid-infused cats had increased glucose transporter-4 (GLUT4) mRNA in the visceral fat, and 37 increased peroxisome proliferative activated receptor-γ2 (PPARγ2) in subcutaneous fat; 38 adiponectin expression was not affected in any tissue. Lipid-infused cats developed hepatic 39
steatosis. 40
Although hyperlipidemia induced systemic inflammation, whole-body insulin sensitivity was 41 not impaired after 10 day infusion. Increased circulating adiponectin may have contributed to 42 preventing insulin resistance, possibly by increasing GLUT4 and PPARγ2 transcripts in fat 43
depots. 44
Cats represent an interesting model to study mechanisms of type 2 diabetes [1] [2] [3] . In contrast 47 to commonly used rodent models, cats spontaneously develop a form of diabetes that is 48 clinically and pathologically similar to human type 2 diabetes. Among shared features, 49 diabetic cats are often middle aged, genetics play a role in diabetes risk, obesity and physical 50 inactivity are major predisposing factors, and impaired β-cell function is generally present in 51 diabetic cats. The most striking histological similarity between human type 2 diabetes and 52 feline diabetes is islet amyloidosis that is found in more than 80% of diabetic cats; the 53 majority of diabetic cats have a β-cell loss of about 50%. Even though obese and diabetic cats 54 are often hyperlipidemic, studies have not been performed to test whether cats may also serve 55 as a model to study the pathogenesis of lipid-induced insulin resistance of human type 2 56
diabetes. 57
Circulating triglycerides and non-esterified fatty acids (NEFA) are commonly increased in 58 obesity and in type 2 diabetic patients, and they are regarded as one of the major determinants 59 in the pathogenesis of insulin resistance in both humans and rodent diabetic models [4] . 60 However, precise mechanisms by which excess lipids may impair insulin action in peripheral 61 tissues are incompletely understood. A greater release of cytokines and chemokines, and 62 decreased synthesis of adiponectin from the expanded adipose tissue may contribute to this 63 phenomenon [5] [6] [7] [8] . Further, the induction of an inflammatory response may play a prominent 64 role, since increased concentrations of lipids can also cause insulin resistance through direct 65 activation of nuclear factor (NF)-kB pathways in peripheral insulin sensitive tissues [9] [10] [11] . In 66 addition, obesity and type 2 diabetes in humans and rodent models are frequently 67 accompanied by decreased expression of the glucose transporter-4 (GLUT4) and the 68 peroxisome proliferative activated receptor-γ2 (PPARγ2) in fat depots or skeletal muscle 69 [12, 13] . Both gene products are crucial in maintaining insulin sensitivity, and hyperlipidemia 70 may contribute to downregulation of their expression [14] . 71 causes whole-body insulin resistance and to test whether this is accompanied by activation of 73 a systemic inflammatory response and by decreased circulating adiponectin. In addition, we 74 tested whether hyperlipidemia induces an upregulation of genes frequently associated with 75 insulin resistance (such as cytokines and chemokines), and a downregulation of genes that 76 sustain insulin sensitivity (such as adiponectin, GLUT4 and PPARγ2) in peripheral insulin 77 sensitive tissues [12] . 78
To investigate the mechanisms through which excess lipids impair insulin sensitivity in vivo, 79 infusion protocols should allow steady and long-term hyperlipidemia at a specific target 80
concentration. This can be obtained by frequently adjusting the rate of lipid infusion. Our 81 study was therefore performed in cats that were infused for 10 days with lipids to clamp 82 plasma triglycerides at the approximate concentration found in untreated feline diabetes 83 (triglycerides: 3-7 mmol/l) [15] . In the large majority of previous infusion studies in humans 84 and rodents, lipids were typically administered for a limited period of time (i.e., few hours, up 85 to 2 days) and at a constant infusion rate. A specific concentration of hyperlipidemia could 86 not be maintained and often very high levels of triglycerides and NEFA were achieved 87 Louis, MO, USA). Cats had free access to water and were fed twice daily with a commercial 96 cat diet (PVD Feline DM Diet, Nestlé-Purina); they were fed the same amount of diet per kg 97 of body weight. 98
The cats were randomly divided into 2 groups and infused over 10 days through a jugular 99
catheter [20] . Six cats received a lipid emulsion (Lipovenoes 10%, Fresenius-Kabi, Bad 100
Homburg, Germany). The emulsion consisted of triglycerides, including the following fatty 101 acids: palmitic acid (C16:0) 9%, stearic acid (C18:0) 4%, oleic acid (C18:1, n-9) 26%, 102 linoleic acid (C18:2, n-6) 54%, and linolenic acid (C18:3, n-3) 8%. Blood triglycerides were 103 measured 2-3 times per day to target concentrations at 3-7 mmol/l. Similar total triglyceride 104 concentrations are found in untreated diabetic cats [15] . Five cats served as controls and were 105 infused with saline. Infusions were given to conscious cats. The site of the jugular catheter 106 implantation was disinfected once daily and examined to identify gross signs of local 107 inflammation (e.g., redness, oedema, purulent exudates). Rectal temperature was measured 108 before each meal. 109
110

Biochemical measurements 111
Blood concentrations of glucose, triglycerides, NEFA and insulin were measured daily as 112 (diluted with saline to a final concentration of 25%) was administered via the jugular catheter. 129
Glucose and insulin were measured before the bolus and at 30, 60, 90 and 120 min thereafter. 130
To estimate sensitivity to insulin, the whole-body insulin sensitivity index was calculated as 131 described by Matsuda and DeFronzo [22] . 132 133
Real-time PCR 134
After the IVGTT, cats were euthanized with an intravenous overdose of barbiturate and tissue 135 samples were collected within 30 minutes. Visceral fat was collected from near the jejunum, 136 subcutaneous fat from the inguinal area, liver from the right caudal hepatic lobe and skeletal 137 muscle from the musculus vastus lateralis. The samples were immediately frozen in liquid 138 nitrogen and stored at -80 ºC. 139 oligonucleotides suitable for SYBR-Green detection of adiponectin, glucose transporter-1 142 (GLUT1), GLUT4, peroxisome proliferative activated receptor-γ1 (PPARγ1), PPARγ2, MCP-143 1 as previously described [23] . Sets of primers and probes were also designed for the above 144 targets and for interleukin (IL)-8 (Table 1) . For the cytokines IL-1β, IL-6 and tumor necrosis 145 factor (TNF)-α available oligonucleotide sequences were used [24] . All probes were labelled 146 at the 5′-end with FAM (6-carboxyfluorescein) and at the 3′-end with TAMRA (5,6-147 tetramethylrhodamine). PCR reactions consisted of 12.5 µl qPCR Mastermix (Eurogentec, 148
Seraing, Belgium), primers and probe to final concentrations of 900 nM and 250 nM, 149 respectively, and 5 µl of cDNA diluted 1:50 in a 25 µl total reaction volume. Cycling 150 parameters were an initial denaturation of 10 min at 95 °C, followed by 45 cycles of 95 °C for 151 15 s and 60 °C for 1 min. cDNA samples were run in triplicate and transcripts were quantified 152 using the relative standard curve method. A template-free control and a sample without 153 reverse transcriptase were included in each amplification run. Gene expression was 154 normalized to the respective quantities of glyceraldehyde-3-phosphate dehydrogenase 155 (GAPDH). PCR product identity was confirmed by DNA sequencing. 156
157
Western blotting 158
Visceral and subcutaneous adipose tissue samples were homogenized in lysis buffer (Santa 159
Cruz Biotechnology, Santa Cruz, CA, USA). Homogenates were centrifuged at 15000 g for 160 10 min (4 °C) and proteins were quantified in the supernatant. For immunoblotting, 70 µg of 161 protein homogenate was diluted in sodium dodecyl sulfate (SDS) buffer and separated on a 162 10% SDS-polyacrylamide gel. Proteins were transferred to nitrocellulose membranes and 163 blocked with non-fat milk for 90 min at room temperature. Membranes were incubated 164 overnight at 4 °C with a 1:750 dilution of a rabbit antimouse GLUT4 antiserum (GT41-S, 165
were incubated with a horseradish peroxidase-conjugated donkey-anti-rabbit IgG (Santa 167 Cruz) for 1 h at room temperature, followed by chemiluminescent detection. Western blotting 168 was quantified by densitometry using β-actin as loading control. Peptide competition assay 169 was performed with mouse GLUT4 blocking peptide (GT41-P, Alpha Diagnostic) to confirm 170 specificity. 171
Histopathology 173
From the collected samples of visceral and subcutaneous fat and liver, one aliquot each was 174
formalin-fixed for 24 h and paraffin-embedded. Paraffin sections were stained with hemalum. To exclude that sustained infusion with the lipid emulsion led to bacteremia, which may 185 contribute to inflammation, detection of bacteria was assessed in blood samples collected at 186 day 10 in all cats with PCR amplification of the 16S rDNA using universal primers [25] . 187 (GraphPad, San Diego, CA, USA). Results in lipid-and saline-infused cats were compared 191 using the Mann-Whitney test. Significance was set at p<0.05. 192
Plasma triglyceride concentration was successfully targeted between 3-7 mmol/l throughout 195 infusion (Fig. 1A) ; NEFA area under the curve during the infusion period was significantly 196 higher in lipid-infused cats than in cats receiving saline (i.e., average increase of 1.7-fold) 197 (Fig. 1B) . Glucose and insulin concentrations did not differ between groups (Fig. 1C,D) . Ten-198 day lipid but not saline infusion increased body weight, on average by 10.7% [20] . 199
On day 10, total adiponectin plasma concentration was approximately 2-fold higher in lipid-200 infused than in saline-infused cats ( Fig. 2A) . Concentrations of the inflammatory proteins 201 AGP and MCP-1 were 2-to 3-fold increased in lipid-infused cats (Fig. 2B,C 
Insulin sensitivity 207
Baseline insulin sensitivity calculated with HOMA was not different between lipid-infused 208 cats and cats receiving saline during the infusion period (Fig. 3A) . On day 10, whole-body 209 insulin sensitivity calculated after the IVGTT was similar in the two groups (Fig. 3B) . In visceral fat, the protein content of GLUT4, as assessed by Western blotting, was higher in 221 lipid-infused than saline-infused cats (Fig. 4A,B) . The amount of GLUT4 protein was not 222 significantly increased in the subcutaneous fat of lipid-infused cats (Fig. 4C) . 223
224
Histopathology 225
At the termination of infusion, the average cross-sectional size of visceral and subcutaneous 226 adipocytes did not differ between groups, whereas that of hepatocytes was almost 30% larger 227 in lipid-infused than in saline-infused cats (Fig. 5A ). With Oil red O staining, more than 50% 228 of the cross-sectional area of the liver was occupied by large lipid droplets in lipid-infused 229 cats, indicating the development of hepatic steatosis. In saline-infused cats lipid droplets 230 occupied approximately 5% of the liver cross-sectional area and were comparably small (Fig.  231 
5B,C). 232
triglycerides at concentrations found in feline diabetes; lipid infusion led to a 1.7 fold-increase 235 of plasma total NEFA, similar to concentrations observed in untreated diabetic cats [15] . 236
Interestingly, the sustained increase of triglycerides and total NEFA did not impair whole-237 body insulin sensitivity, despite the activation of a systemic inflammatory response in cats. 238
Circulating total adiponectin was increased, and the expression of GLUT4 and PPARγ2 239 transcripts in visceral or subcutaneous fat was upregulated. 240 Different from our results in cats, former studies in humans and rodents consistently showed 241 an impairment of insulin sensitivity following lipid-infusion [10,11,17-19,26]. The 242 composition of the lipid emulsion used in our study is similar to that used in most studies in 243 humans and rodents [10,11,17-19,26], and contains more than 50% of all fatty acids as 244 linoleic acid and less than 20% of saturated fatty acids (i.e., palmitic acid, C16:0; stearic acid, 245 C18:0). Hence, it may be argued that the effect of hyperlipidemia on insulin sensitivity differs 246 between cats and humans or rodents. It is however important to realize that, even though 247 previously used emulsions were similar to ours, infusion times have been much shorter. 248
Infusions in previous studies were usually carried out for 2-5 hours, and only in few cases up 249 to a maximum of 2 days. Further, infusions were typically given at constant and relatively 250 high rates. Experiments in humans and rodents have not been conducted to verify whether 251 insulin sensitivity is still impaired after 10 days of lipid infusion in the diabetic range. It is 252 therefore possible that rather than reflecting a species-specific difference in our cat study, 253
lipid-induced insulin resistance that was observed during short-term lipid infusion in humans 254
and rodents may no longer be present after 10 day infusion due to some as yet unknown 255 compensatory mechanisms. 256
At least in humans, insulin resistance seems to be associated with a particular fatty acid 257 pattern. A comparison between the lipid fatty acid composition of serum in insulin resistant 258 common for both disorders; this is in particular represented by an increased proportion of 260 palmitic acid and low concentrations of linoleic acid (C18:2, n-6) [27, 28] . Similar findings 261 were reported when insulin sensitivity was measured in a group of healthy subjects. 262
Significant associations were seen between fatty acid concentrations in serum and insulin 263 responsiveness [29], i.e. lower insulin sensitivity was observed in individuals with high 264 palmitic acid and low linoleic acid concentrations. Because the lipid emulsion in our study 265 was largely composed of triglycerides containing linoleic acid (54%) and only small amounts 266 of palmitic acid (9%), it is conceivable that the specific fatty acid composition contributed to 267 maintaining insulin sensitivity in cats in our study, despite the increase in body weight. In lipid-infused cats circulating total adiponectin was 2-fold higher than in control cats. This 317 finding was unexpected because previous studies reported lower adiponectin concentrations in 318 obese humans and cats [37, 38] . Low total adiponectin, particularly the isoform with high 319 molecular weight which was not specifically measured in our study, is typically considered a 320 strong and independent predictor of insulin resistance, at least in humans and rodents [37, 39] . 321
Thus, the fact that circulating adiponectin was not decreased in lipid-infused cats is in 322 principle compatible with the unaltered whole-body insulin sensitivity in these animals. The 323 source of increased total plasma adiponectin remains unknown since tissue expression at the 324 mRNA level was not increased in any investigated tissue. A decreased clearance of 325 adiponectin can therefore not be excluded. It is also possible that increased adiponectin was 326 due to augmented body fat mass following adipocyte hyperplasia. 327
Notably, elevated adiponectin levels have been suggested to play a direct role in the 328 expression of several genes with a beneficial effect on insulin sensitivity. For instance, in vivo 329 data with mice overexpressing adiponectin and in vitro data with pig adipocytes treated with 330 adiponectin indicate an increased expression of the transcription factor PPARγ2 and a 331 decreased expression of NF-kB; both factors may contribute to a downregulation of 332 transcripts of cytokines, thus preventing insulin resistance [40, 41] . Furthermore, rat 333 adipocytes treated with adiponectin show improved glucose uptake, which may partly be due 334 to AMP kinase activation; AMP kinase enhances cellular glucose transport due to increased 335 GLUT4 transcription and translocation [42] . Hence, increased adiponectin may have 336 promoted the expression of PPARγ2 and GLUT4 in adipose tissues of lipid-infused cats in 337 our study. Similarly, mRNA transcripts of PPARγ2 and GLUT4 were upregulated in visceral 338 adipose tissue in lipid-infused rats [14] . In that study, the role of adiponectin was not 339 specifically investigated. 340
In conclusion, 10-day hyperlipidemic clamp resulted in increased serum concentrations of 341 triglycerides and total NEFA similar to those seen in untreated feline diabetes. This was not 342 associated with whole-body insulin resistance in cats, despite signs of systemic inflammation 343 and a 10% increase in body weight. Increased circulating adiponectin may have helped to 344 sustain insulin sensitivity at the level of control animals, possibly through increased GLUT4 345 and PPARγ2 transcripts in fat depots. Further studies are needed to verify whether insulin 346 sensitivity is differentially affected in adipose tissues, liver and skeletal muscles of cats 347 rendered hyperlipidemic. Although feline diabetes and human type 2 diabetes share many 348 common pathogenic mechanisms, including genetic predisposition, obesity-induced insulin 349 resistance and islet amyloidosis [1-3], our study may suggest that lipid metabolism and its 350 association to insulin resistance differs in cats. The infusion protocol used here specifically 351 targeted total serum lipids at the concentrations observed in diabetic cats. We believe that this 352 protocol allows to better mimic the naturally occurring disease than by infusing lipids at a 353 constant rate (i.e., previous studies in humans and rodents); however, it is possible that the 354 infusion period was not long enough to cause insulin resistance or that infusion of a different 355 fatty acid emulsion may be necessary. Results are normalized to β-actin. 505 
